U-Blot® Research Grade caxmotabartCat. No. WA2584$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade caxmotabartCat. No. WA2584
U-Blot® Research Grade CatumaxomabCat. No. WA2583
U-Blot® Research Grade CasirivimabCat. No. WA2582
U-Blot® Research Grade CasdozokitugCat. No. WA2581
U-Blot® Research Grade CarotuximabCat. No. WA2580
U-Blot® Research Grade CarlumabCat. No. WA2579
U-Blot® Research Grade CapromabCat. No. WA2578
U-Blot® Research Grade CaplacizumabCat. No. WA2577
U-Blot® Research Grade CantuzumabCat. No. WA2576
U-Blot® Research Grade CanakinumabCat. No. WA2575
U-Blot® Research Grade camtarkibartCat. No. WA2574
U-Blot® Research Grade CamrelizumabCat. No. WA2573